Judge Voids PDL Antibody Patent In MedImmune Suit
A federal judge has dealt PDL BioPharma Inc. a major blow, invalidating a patent covering the engineering of antibodies and ruling that MedImmune LLC did not violate a licensing agreement with...To view the full article, register now.
Already a subscriber? Click here to view full article